News Release

<< Back

Ra Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 21, 2019-- Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Ramin Farzaneh-Far, M.D., Chief Medical Officer of Ra Pharma, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 2:30 p.m. E.T. The conference is being held at the Lotte New York Palace, New York, NY.

The presentation will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit:

Source: Ra Pharmaceuticals, Inc.

Ra Pharmaceuticals
Natalie Wildenradt, 617-209-5324

Argot Partners
David Rosen, 212-600-1902